eCite Digital Repository

Reach-Through Rights in Biomedical Patent Licensing: A Comparative Analysis of their Anti-Competitive Reach

Citation

Nielsen, JL, Reach-Through Rights in Biomedical Patent Licensing: A Comparative Analysis of their Anti-Competitive Reach, Federal Law Review, 32, (2) pp. 169-204. ISSN 0067-205X (2004) [Refereed Article]


Preview
PDF
Restricted - Request a copy
707Kb
  

Copyright Statement

Copyright 2004 Federal Law Review

Official URL: http://www.federallawreview.com.au/

Abstract

Medical biotechnology offers vast opportunity for the treatment of human genetic conditions, including the development and improvement of drugs, diagnostic capabilities and therapeutic techniques. Australian health and medical research has a rich and proud history. This has been recognised in numerous federal government reports, which examine the sustainability of research momentum and the ability of the Australian industry to capitalise on this research base. Australia's increasing $1 billion trade deficit in pharmaceuticals, medical equipment and other health and medical industries has been a major impetus for the push to develop Australia's medical research base.

Item Details

Item Type:Refereed Article
Research Division:Law and Legal Studies
Research Group:Law
Research Field:Law not elsewhere classified
Objective Division:Law, Politics and Community Services
Objective Group:Justice and the Law
Objective Field:Justice and the Law not elsewhere classified
Author:Nielsen, JL (Dr Jane Nielsen)
ID Code:30172
Year Published:2004
Deposited By:Law
Deposited On:2004-08-01
Last Modified:2009-07-20
Downloads:4 View Download Statistics

Repository Staff Only: item control page